169 related articles for article (PubMed ID: 19920185)
1. Acyl-CoA synthetase VL3 knockdown inhibits human glioma cell proliferation and tumorigenicity.
Pei Z; Sun P; Huang P; Lal B; Laterra J; Watkins PA
Cancer Res; 2009 Dec; 69(24):9175-82. PubMed ID: 19920185
[TBL] [Abstract][Full Text] [Related]
2. Lipid metabolism enzyme ACSVL3 supports glioblastoma stem cell maintenance and tumorigenicity.
Sun P; Xia S; Lal B; Shi X; Yang KS; Watkins PA; Laterra J
BMC Cancer; 2014 Jun; 14():401. PubMed ID: 24893952
[TBL] [Abstract][Full Text] [Related]
3. Very long-chain acyl-CoA synthetase 3: overexpression and growth dependence in lung cancer.
Pei Z; Fraisl P; Shi X; Gabrielson E; Forss-Petter S; Berger J; Watkins PA
PLoS One; 2013; 8(7):e69392. PubMed ID: 23936004
[TBL] [Abstract][Full Text] [Related]
4. EGFRvIII and c-Met pathway inhibitors synergize against PTEN-null/EGFRvIII+ glioblastoma xenografts.
Lal B; Goodwin CR; Sang Y; Foss CA; Cornet K; Muzamil S; Pomper MG; Kim J; Laterra J
Mol Cancer Ther; 2009 Jul; 8(7):1751-60. PubMed ID: 19584231
[TBL] [Abstract][Full Text] [Related]
5. Mouse very long-chain Acyl-CoA synthetase 3/fatty acid transport protein 3 catalyzes fatty acid activation but not fatty acid transport in MA-10 cells.
Pei Z; Fraisl P; Berger J; Jia Z; Forss-Petter S; Watkins PA
J Biol Chem; 2004 Dec; 279(52):54454-62. PubMed ID: 15469937
[TBL] [Abstract][Full Text] [Related]
6. Very long-chain acyl-CoA synthetase 3 mediates onco-sphingolipid metabolism in malignant glioma.
Kolar EA; Shi X; Clay EM; Moser AB; Lal B; Nirujogi RS; Pandey A; Bandaru VVR; Laterra J; Pei Z; Watkins PA
Med Res Arch; 2021 May; 9(5):. PubMed ID: 34395855
[TBL] [Abstract][Full Text] [Related]
7. Depleting glioblastoma cells of very long-chain acyl-CoA synthetase 3 (ACSVL3) produces metabolic alterations in non-lipid pathways.
Kolar EA; Shi X; Clay EM; Liu Y; Xia S; Zhang C; Le A; Watkins PA
bioRxiv; 2023 Sep; ():. PubMed ID: 37786718
[TBL] [Abstract][Full Text] [Related]
8. VERY LONG-CHAIN ACYL-CoA SYNTHETASE-3 (ACSVL3) PROMOTES THE MALIGNANT GROWTH BEHAVIOR OF U87 GLIOMA CELLS VIA CHANGES IN CELL CYCLE WITHOUT AFFECTING APOPTOSIS.
Yang H; Shi X; Kolar EA; Clay EM; Xia S; Pei Z; Watkins PA
bioRxiv; 2023 May; ():. PubMed ID: 37205435
[TBL] [Abstract][Full Text] [Related]
9. Cyr61 mediates hepatocyte growth factor-dependent tumor cell growth, migration, and Akt activation.
Goodwin CR; Lal B; Zhou X; Ho S; Xia S; Taeger A; Murray J; Laterra J
Cancer Res; 2010 Apr; 70(7):2932-41. PubMed ID: 20233866
[TBL] [Abstract][Full Text] [Related]
10. Tetraarsenic oxide-induced inhibition of malignant glioma cell invasion in vitro via a decrease in matrix metalloproteinase secretion and protein kinase B phosphorylation.
Gwak HS; Park MJ; Park IC; Woo SH; Jin HO; Rhee CH; Jung HW
J Neurosurg; 2014 Dec; 121(6):1483-91. PubMed ID: 25303017
[TBL] [Abstract][Full Text] [Related]
11. CD164 regulates proliferation and apoptosis by targeting PTEN in human glioma.
Tu M; Cai L; Zheng W; Su Z; Chen Y; Qi S
Mol Med Rep; 2017 Apr; 15(4):1713-1721. PubMed ID: 28259931
[TBL] [Abstract][Full Text] [Related]
12. Integrin αVβ3 silencing sensitizes malignant glioma cells to temozolomide by suppression of homologous recombination repair.
Christmann M; Diesler K; Majhen D; Steigerwald C; Berte N; Freund H; Stojanović N; Kaina B; Osmak M; Ambriović-Ristov A; Tomicic MT
Oncotarget; 2017 Apr; 8(17):27754-27771. PubMed ID: 27487141
[TBL] [Abstract][Full Text] [Related]
13. Histone deacetylase 1 promotes glioblastoma cell proliferation and invasion via activation of PI3K/AKT and MEK/ERK signaling pathways.
Li S; Chen X; Mao L; Zahid KR; Wen J; Zhang L; Zhang M; Duan J; Duan J; Yin X; Wang Y; Zhao L; Tang X; Wang X; Xu G
Brain Res; 2018 Aug; 1692():154-162. PubMed ID: 29782850
[TBL] [Abstract][Full Text] [Related]
14. Anti-Tumor Effects of Sodium Meta-Arsenite in Glioblastoma Cells with Higher Akt Activities.
Lee EJ; Sung JY; Koo KH; Park JB; Kim DH; Shim J; Lee CH; Park J; Kim YN
Int J Mol Sci; 2020 Nov; 21(23):. PubMed ID: 33256086
[TBL] [Abstract][Full Text] [Related]
15. Targeting protein kinase CK2 suppresses prosurvival signaling pathways and growth of glioblastoma.
Zheng Y; McFarland BC; Drygin D; Yu H; Bellis SL; Kim H; Bredel M; Benveniste EN
Clin Cancer Res; 2013 Dec; 19(23):6484-94. PubMed ID: 24036851
[TBL] [Abstract][Full Text] [Related]
16. Targeting integrin-linked kinase inhibits Akt signaling pathways and decreases tumor progression of human glioblastoma.
Koul D; Shen R; Bergh S; Lu Y; de Groot JF; Liu TJ; Mills GB; Yung WK
Mol Cancer Ther; 2005 Nov; 4(11):1681-8. PubMed ID: 16275989
[TBL] [Abstract][Full Text] [Related]
17. AKT/GSK-3β/β-catenin signaling pathway participates in erythropoietin-promoted glioma proliferation.
Tang Z; Yang G; Wang X; Chen F; Liao Z; Zhang Z; Liu Z; Zeng W; Fang M; Wang W; Sun X; Huo G
J Neurooncol; 2020 Sep; 149(2):231-242. PubMed ID: 32909117
[TBL] [Abstract][Full Text] [Related]
18. The plasticity of oncogene addiction: implications for targeted therapies directed to receptor tyrosine kinases.
Pillay V; Allaf L; Wilding AL; Donoghue JF; Court NW; Greenall SA; Scott AM; Johns TG
Neoplasia; 2009 May; 11(5):448-58, 2 p following 458. PubMed ID: 19412429
[TBL] [Abstract][Full Text] [Related]
19. Cell cycle-related kinase: a novel candidate oncogene in human glioblastoma.
Ng SS; Cheung YT; An XM; Chen YC; Li M; Li GH; Cheung W; Sze J; Lai L; Peng Y; Xia HH; Wong BC; Leung SY; Xie D; He ML; Kung HF; Lin MC
J Natl Cancer Inst; 2007 Jun; 99(12):936-48. PubMed ID: 17565152
[TBL] [Abstract][Full Text] [Related]
20. Targeting TWIST1 through loss of function inhibits tumorigenicity of human glioblastoma.
Mikheev AM; Mikheeva SA; Severs LJ; Funk CC; Huang L; McFaline-Figueroa JL; Schwensen J; Trapnell C; Price ND; Wong S; Rostomily RC
Mol Oncol; 2018 Jun; 12(7):1188-1202. PubMed ID: 29754406
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
